Tarsus Pharmaceuticals (TARS)

• Market cap: $2.9B
• 1 day: 0.23%
• 5 days: -0.74%
• 1 month: -0.25%
• 3 months: 42.34%
• 6 months: 44.14%
• Year to date: 23.75%
• 1 year: 45.86%
• 5 years: 194.31%
• 10 years: 231.63%
• Sector: Healthcare
• Industry: Biotechnology

About: Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Employees: 323